Ana gezinime atla Aramaya atla Ana içeriğe atla

Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study (BMC Cancer, (2021), 21, 1, (1021), 10.1186/s12885-021-08738-z)

  • Mustafa Erman
  • , Bivas Biswas
  • , Pongwut Danchaivijitr
  • , Lingwu Chen
  • , Yoke Fui Wong
  • , Tarek Hashem
  • , Chun Sen Lim
  • , Bulent Karabulut
  • , Hsiao Jen Chung
  • , Chandrasekhar Chikatapu
  • , Sara Ingles
  • , Khemaies Slimane
  • , Ravindran Kanesvaran

Araştırma sonucu: Dergiye katkıYorum/tartışma

3 Alıntılar (Scopus)

Özet

Following publication of the original article [1], the authors identified an error in the author names of Mustafa Erman, Bivas Biswas, Pongwut Danchaivijitr, Lingwu Chen and Chandrasekhar Chikatapu. The given names and family names were erroneously transposed. Further to this, figure 1 has been updated. The line colors in “C” section for “Poor” and “Unknown” have been changed to align with Figure B and legend to match the line colors. The author group has been updated above and the original article [1] has been corrected.

Orijinal dilİngilizce
Makale numarası1191
DergiBMC Cancer
Hacim21
Basın numarası1
DOI'lar
Yayın durumuYayınlandı - Ara 2021

BM SKH

Bu sonuç, aşağıdaki Sürdürülebilir Kalkınma Hedefine/Hedeflerine katkıda bulunur

  1. SKH 3 - Sağlık ve Kaliteli Yaşam
    SKH 3 Sağlık ve Kaliteli Yaşam

Parmak izi

Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study (BMC Cancer, (2021), 21, 1, (1021), 10.1186/s12885-021-08738-z)' araştırma başlıklarına git. Birlikte benzersiz bir parmak izi oluştururlar.

Bundan alıntı yap